Airways disease research

Globally 400 million people live with either chronic obstructive pulmonary disease (COPD) or Asthma. Together they are the number 1 cause of chronic respiratory ill health and mortality. Critically both of these respiratory diseases have complex, poorly understood aetiology and co-morbidities. Our focus, both clinically and in research, is on Asthma and Chronic Obstructive Pulmonary Disease (COPD), both of which can cause shortness of breath. We specialise in assessing and managing patients with airways disease that may need tests or interventions unavailable in the community or at other hospitals. Our research focuses on therapies to improve patient outcomes, whether that be through drugs, devices or psychology. We are also looking at the relationship between lung health and other long term conditions (co-morbidities).

When inhaling, air passes down the wind pipe (trachea) which divides into progressively smaller and smaller airways until the reaching small sacs (alveoli) where the gases in the air e.g. oxygen can pass through into the blood. When exhaling this process happens in reverse. Many conditions can affect the airways making it harder for air to pass through them.


For more details about any aspect of our airways disease work, or to discuss collaborating with us, please contact either: Anna Morley or James Dodd


Edit this page